Citadel Advisors’s Esperion Therapeutics ESPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.28M | Sell |
467,610
-282,493
| -38% | -$894K | ﹤0.01% | 7114 |
|
|
2025
Q4 | $2.78M | Sell |
750,103
-780,261
| -51% | -$2.52M | ﹤0.01% | 5316 |
|
|
2025
Q3 | $4.06M | Sell |
1,530,364
-798,769
| -34% | -$1.54M | ﹤0.01% | 4733 |
|
|
2025
Q2 | $2.29M | Buy |
2,329,133
+238,028
| +11% | +$238K | ﹤0.01% | 5450 |
|
|
2025
Q1 | $3.01M | Buy |
2,091,105
+336,473
| +19% | +$620K | ﹤0.01% | 4762 |
|
|
2024
Q4 | $3.86M | Buy |
1,754,632
+1,621,016
| +1,213% | +$3.78M | ﹤0.01% | 4394 |
|
|
2024
Q3 | $220K | Sell |
133,616
-1,388,161
| -91% | -$2.8M | ﹤0.01% | 9950 |
|
|
2024
Q2 | $3.38M | Sell |
1,521,777
-1,840,433
| -55% | -$4.33M | ﹤0.01% | 4371 |
|
|
2024
Q1 | $9.01M | Buy |
3,362,210
+2,899,928
| +627% | +$7.05M | ﹤0.01% | 3069 |
|
|
2023
Q4 | $1.38M | Sell |
462,282
-189,266
| -29% | -$245K | ﹤0.01% | 6037 |
|
|
2023
Q3 | $639K | Sell |
651,548
-55,227
| -8% | -$79.9K | ﹤0.01% | 7538 |
|
|
2023
Q2 | $982K | Sell |
706,775
-31,406
| -4% | -$43.9K | ﹤0.01% | 6487 |
|
|
2023
Q1 | $1.17M | Sell |
738,181
-811,815
| -52% | -$4.19M | ﹤0.01% | 6429 |
|
|
2022
Q4 | $9.66M | Buy |
1,549,996
+1,035,258
| +201% | +$7.4M | ﹤0.01% | 2891 |
|
|
2022
Q3 | $3.45M | Buy |
514,738
+413,144
| +407% | +$2.84M | ﹤0.01% | 4527 |
|
|
2022
Q2 | $646K | Buy |
101,594
+62,276
| +158% | +$353K | ﹤0.01% | 8070 |
|
|
2022
Q1 | $182K | Sell |
39,318
-192,499
| -83% | -$826K | ﹤0.01% | 11645 |
|
|
2021
Q4 | $1.16M | Buy |
231,817
+127,850
| +123% | +$1.02M | ﹤0.01% | 7584 |
|
|
2021
Q3 | $1.25M | Buy |
103,967
+40,954
| +65% | +$596K | ﹤0.01% | 7552 |
|
|
2021
Q2 | $1.33M | Buy |
63,013
+9,499
| +18% | +$229K | ﹤0.01% | 7596 |
|
|
2021
Q1 | $1.5M | Sell |
53,514
-152,860
| -74% | -$4.51M | ﹤0.01% | 7097 |
|
|
2020
Q4 | $5.37M | Buy |
206,374
+170,207
| +471% | +$5.1M | ﹤0.01% | 3561 |
|
|
2020
Q3 | $1.34M | Sell |
36,167
-44,871
| -55% | -$1.78M | ﹤0.01% | 5476 |
|
|
2020
Q2 | $4.16M | Sell |
81,038
-109,029
| -57% | -$4.56M | ﹤0.01% | 3346 |
|
|
2020
Q1 | $5.99M | Buy |
190,067
+25,242
| +15% | +$1.33M | ﹤0.01% | 2485 |
|
|
2019
Q4 | $9.83M | Sell |
164,825
-137,039
| -45% | -$6.16M | ﹤0.01% | 2222 |
|
|
2019
Q3 | $11.1M | Buy |
301,864
+93,101
| +45% | +$3.69M | 0.01% | 2099 |
|
|
2019
Q2 | $9.71M | Buy |
208,763
+108,847
| +109% | +$5.11M | ﹤0.01% | 2211 |
|
|
2019
Q1 | $4.01M | Buy |
99,916
+36,971
| +59% | +$1.66M | ﹤0.01% | 3302 |
|
|
2018
Q4 | $2.9M | Buy |
62,945
+1,515
| +2% | +$73K | ﹤0.01% | 3576 |
|
|
2018
Q3 | $2.73M | Buy |
61,430
+44,487
| +263% | +$2.04M | ﹤0.01% | 3880 |
|
|
2018
Q2 | $664K | Sell |
16,943
-441,084
| -96% | -$22.3M | ﹤0.01% | 5906 |
|
|
2018
Q1 | $33.1M | Buy |
458,027
+284,335
| +164% | +$20.9M | 0.02% | 788 |
|
|
2017
Q4 | $11.4M | Buy |
173,692
+115,360
| +198% | +$6.21M | 0.01% | 1598 |
|
|
2017
Q3 | $2.92M | Buy |
+58,332
| New | +$2.81M | ﹤0.01% | 2958 |
|
|
2016
Q4 | – | Sell |
-35,595
| Closed | -$424K | – | 7390 |
|
|
2016
Q3 | $493K | Buy |
35,595
+17,643
| +98% | +$200K | ﹤0.01% | 4883 |
|
|
2016
Q2 | $177K | Sell |
17,952
-5,978
| -25% | -$99.1K | ﹤0.01% | 5915 |
|
|
2016
Q1 | $405K | Buy |
23,930
+16,981
| +244% | +$273K | ﹤0.01% | 4697 |
|
|
2015
Q4 | $155K | Sell |
6,949
-166,165
| -96% | -$4.19M | ﹤0.01% | 6162 |
|
|
2015
Q3 | $4.08M | Buy |
173,114
+145,408
| +525% | +$9.13M | ﹤0.01% | 2139 |
|
|
2015
Q2 | $2.27M | Sell |
27,706
-85,231
| -75% | -$8.34M | ﹤0.01% | 2925 |
|
|
2015
Q1 | $10.5M | Buy |
+112,937
| New | +$7.29M | 0.01% | 1416 |
|
Other funds holding ESPR
WA
TSC
O
VCM
